Search

Your search keyword '"A. Prejbisz"' showing total 1,517 results

Search Constraints

Start Over You searched for: Author "A. Prejbisz" Remove constraint Author: "A. Prejbisz"
1,517 results on '"A. Prejbisz"'

Search Results

1. Physicians’ attitudes toward beta‐blockers for the treatment of hypertension in Italy, Poland, and Turkey

2. The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)

3. Randomised, double-blind, placebo-controlled study evaluating the effect of allopurinol on the risk of cardiovascular events in patients with high and very high cardiovascular risk, including the presence of long-COVID-19 syndrome: the ALL-VASCOR study protocol

4. Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels

5. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

6. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

7. Wstęp

10. Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension

11. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort

12. Metabolic syndrome – a new definition and management guidelines. A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, 'Club 30' Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons

13. The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)

14. Author Correction: Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases

15. Whole blood methylome-derived features to discriminate endocrine hypertension

17. Genetic testing for inherited cardiovascular diseases. A position statement of the Polish Cardiac Society endorsed by Polish Society of Human Genetics and Cardiovascular Patient Communities

19. PREGNANCY-RELATED SPONTANEOUS CORONARY ARTERY DISSECTION: CLINICAL PROFILE, PREGNANCY COMPLICATIONS AND OUTCOMES- SCAD-POL REGISTRY ANALYSIS

20. Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma

21. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

22. Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases

23. Hypertension healthcare professional beliefs and behaviour regarding patient medication adherence: a survey conducted among European Society of Hypertension Centres of Excellence

24. Optimized procedures for testing plasma metanephrines in patients on hemodialysis

25. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment

26. Pheochromocytoma and Paraganglioma

27. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery

28. Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study

29. Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension

30. Renal denervation: can we press the 'ON' button again in 2020?

31. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

37. Ambulatory blood pressure monitoring in treated patients with hypertension in the COVID-19 pandemic - The study of European society of hypertension (ESH ABPM COVID-19 study)

38. Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.

39. Use of antihypertensive drug classes and combination therapies during the COVID-19 pandemic in Poland: a cross-sectional, nation-wide study 2019-2021

40. Egzamin z kardiologii. Tom 1

41. Physicians' attitudes toward beta‐blockers for the treatment of hypertension in Italy, Poland, and Turkey.

42. Genetic testing for inherited cardiovascular diseases. A position statement of the Polish Cardiac Society endorsed by the Polish Society of Human Genetics and Cardiovascular Patient Communities.

43. Risks and benefits of renal artery stenting in fibromuscular dysplasia: Lessons from the ARCADIA-POL study

44. Predicting Hypertension Subtypes with Machine Learning Using Targeted Metabolites and Their Ratios

45. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic

46. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension*

47. Genetic Study of PHACTR1 and Fibromuscular Dysplasia, Meta-Analysis and Effects on Clinical Features of Patients: The ARCADIA-POL Study

48. Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions: The ARCADIA-POL Study

49. Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension

Catalog

Books, media, physical & digital resources